Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
about
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group StudyGermline MUTYH gene mutations are not frequently found in unselected patients with papillary breast carcinoma.Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients.Genetic screening for gynecological cancer: where are we heading?Advances in Hereditary Colorectal and Pancreatic Cancers.Laboratory Assays in Evaluation of Lynch Syndrome in Patients with Endometrial Carcinoma.Endometrial cancer: Not your grandmother's cancer.Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaTargeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer.Differences in Microsatellite Instability Profiles between Endometrioid and Colorectal Cancers: A Potential Cause for False-Negative Results?Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors o
P2860
Q30361978-053CBD54-7C4D-4C1E-83FA-4B9499EE4E17Q35559296-3E1EE8D7-A13F-455B-A90A-1577B682575BQ36947800-7FA88CFA-4388-4F16-89D5-3336A5EE11A7Q38659935-2C74518B-5F9D-4A6F-861E-F233D50F2BECQ38798530-F5EE8F68-286F-4DB9-A7F5-9F0AEEA0BCD4Q38848447-0BB232BA-666B-4E75-AF2E-C49AD1929E28Q38852405-E0CA7A8B-4146-4280-819B-3898E2C4C8ADQ40073731-C89ECDAE-2C42-4C63-A67E-C1F0A054AA9AQ46540302-011CEED9-0ED5-443B-9F78-3DAB1817D66EQ50720259-F708C2F7-9787-4DE4-AF08-8EB6C5925653Q51346691-A051F64E-B3FD-45C6-A7DA-2DACEFF61592Q58592781-E6E3839C-344D-45C2-8A48-8BF23A23D440
P2860
Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Performance characteristics of ...... sal germline mutation testing.
@en
Performance characteristics of ...... sal germline mutation testing.
@nl
type
label
Performance characteristics of ...... sal germline mutation testing.
@en
Performance characteristics of ...... sal germline mutation testing.
@nl
prefLabel
Performance characteristics of ...... sal germline mutation testing.
@en
Performance characteristics of ...... sal germline mutation testing.
@nl
P2093
P2860
P50
P356
P1433
P1476
Performance characteristics of ...... rsal germline mutation testing
@en
P2093
Alicia A Tone
Amit M Oza
Christine Massey
Golnessa Mojtahedi
Helen J MacKay
Jordan Lerner-Ellis
Lua R Eiriksson
Marcus Q Bernardini
Melyssa Aronson
Sarah E Ferguson
P2860
P304
P356
10.1002/CNCR.28933
P407
P577
2014-07-31T00:00:00Z